BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Domenech M, García E. N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae. Antimicrob Agents Chemother 2017;61:e01992-16. [PMID: 27919900 DOI: 10.1128/AAC.01992-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Llamosí M, Sempere J, Coronel P, Gimeno M, Yuste J, Domenech M. Combination of Cefditoren and N -acetyl- l -Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms. Microbiol Spectr 2022. [DOI: 10.1128/spectrum.03415-22] [Reference Citation Analysis]
2 Sempere J, Llamosí M, Román F, Lago D, González-Camacho F, Pérez-García C, Yuste J, Domenech M. Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-L-cysteine and cysteamine. Sci Rep 2022;12:6668. [PMID: 35461321 DOI: 10.1038/s41598-022-10609-x] [Reference Citation Analysis]
3 Chlumsky O, Smith HJ, Parker AE, Brileya K, Wilking JN, Purkrtova S, Michova H, Ulbrich P, Viktorova J, Demnerova K. Evaluation of the Antimicrobial Efficacy of N-Acetyl-l-Cysteine, Rhamnolipids, and Usnic Acid-Novel Approaches to Fight Food-Borne Pathogens. Int J Mol Sci 2021;22:11307. [PMID: 34768739 DOI: 10.3390/ijms222111307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wong KK, Lee SWH, Kua KP. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence. J Inflamm Res 2021;14:2993-3013. [PMID: 34262324 DOI: 10.2147/JIR.S306849] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
5 Cools F, Delputte P, Cos P. The search for novel treatment strategies for Streptococcus pneumoniae infections. FEMS Microbiol Rev 2021:fuaa072. [PMID: 33399826 DOI: 10.1093/femsre/fuaa072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Devereux G, Wrolstad D, Bourke SJ, Daines CL, Doe S, Dougherty R, Franco R, Innes A, Kopp BT, Lascano J, Layish D, MacGregor G, Murray L, Peckham D, Lucidi V, Lovie E, Robertson J, Fraser-Pitt DJ, O'Neil DA. Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial. PLoS One 2020;15:e0242945. [PMID: 33370348 DOI: 10.1371/journal.pone.0242945] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Valenzuela MV, Domenech M, Mateos-Martínez P, González-Camacho F, de la Campa AG, García MT. Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae. PLoS One 2020;15:e0241780. [PMID: 33141832 DOI: 10.1371/journal.pone.0241780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Domenech M, García E. The N-Acetylglucosaminidase LytB of Streptococcus pneumoniae Is Involved in the Structure and Formation of Biofilms. Appl Environ Microbiol 2020;86:e00280-20. [PMID: 32198170 DOI: 10.1128/AEM.00280-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Nagatomo Y, Shirakura T, Fukuchi K, Takuma T, Tokimatsu I, Niki Y. Monitoring Quinolone Resistance Due to Mutations in GyrA and ParC in <i>Haemophilus Influenzae</i>(2012-17). Showa Univ J Med Sci 2020;32:81-90. [DOI: 10.15369/sujms.32.81] [Reference Citation Analysis]
10 Cattò C, De Vincenti L, Cappitelli F, D'Attoma G, Saponari M, Villa F, Forlani F. Non-Lethal Effects of N-Acetylcysteine on Xylella fastidiosa Strain De Donno Biofilm Formation and Detachment. Microorganisms 2019;7:E656. [PMID: 31817370 DOI: 10.3390/microorganisms7120656] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
11 Jolivet‐gougeon A, Bonnaure‐mallet M. Bacterial Persistence in Biofilms and Antibiotics. Antibiotic Drug Resistance 2019. [DOI: 10.1002/9781119282549.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. PLoS One 2018;13:e0203941. [PMID: 30273348 DOI: 10.1371/journal.pone.0203941] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
13 Domenech M, García E. Fluorescence Imaging of Streptococcus pneumoniae with the Helix pomatia agglutinin (HPA) As a Potential, Rapid Diagnostic Tool. Front Microbiol 2017;8:1333. [PMID: 28769901 DOI: 10.3389/fmicb.2017.01333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]